Abstract
Radiosurgery for lung cancer is a novel and promising concept that warrants thorough review. Stereotactic body radiotherapy enables the selective delivery of an intense dose of high-energy radiation to destroy a tumor with precise targeting. The radiobiology and physics behind the use of radiosurgery are presented, followed by a discussion of promising retrospective and prospective clinical data that has been reported from Japan, Europe, and the United States. The article closes with a discussion of multidisciplinary approaches that include radiosurgery which are on the therapeutic horizon.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Carcinoma, Non-Small-Cell Lung / mortality
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Non-Small-Cell Lung / surgery
-
Dose Fractionation, Radiation
-
Female
-
Humans
-
Lung Neoplasms / mortality
-
Lung Neoplasms / pathology
-
Lung Neoplasms / surgery
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local / pathology*
-
Neoplasm Recurrence, Local / surgery
-
Patient Selection
-
Prognosis
-
Radiosurgery / methods*
-
Risk Assessment
-
Sensitivity and Specificity
-
Survival Analysis
-
Thoracic Neoplasms / mortality
-
Thoracic Neoplasms / pathology*
-
Thoracic Neoplasms / surgery*
-
Treatment Outcome